AGP Past Earnings Performance
Past criteria checks 1/6
AGP has been growing earnings at an average annual rate of 4.1%, while the Pharmaceuticals industry saw earnings growing at 4.1% annually. Revenues have been growing at an average rate of 27.1% per year. AGP's return on equity is 14.7%, and it has net margins of 8.4%.
Key information
4.1%
Earnings growth rate
4.1%
EPS growth rate
| Pharmaceuticals Industry Growth | 20.2% |
| Revenue growth rate | 27.1% |
| Return on equity | 14.7% |
| Net Margin | 8.4% |
| Last Earnings Update | 31 Dec 2023 |
Recent past performance updates
Recent updates
Revenue & Expenses BreakdownBeta
How AGP makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Dec 23 | 18,743 | 1,565 | 5,561 | 0 |
| 30 Sep 23 | 16,937 | 1,500 | 5,099 | 0 |
| 30 Jun 23 | 15,423 | 1,414 | 4,757 | 0 |
| 31 Mar 23 | 14,696 | 1,370 | 4,511 | 0 |
| 31 Dec 22 | 14,459 | 1,570 | 4,173 | 0 |
| 30 Sep 22 | 13,837 | 1,676 | 3,815 | 0 |
| 30 Jun 22 | 12,794 | 1,765 | 3,383 | 0 |
| 31 Mar 22 | 11,336 | 1,919 | 2,889 | 0 |
| 31 Dec 21 | 9,317 | 1,747 | 2,405 | 0 |
| 30 Sep 21 | 7,895 | 1,533 | 2,126 | 0 |
| 30 Jun 21 | 7,420 | 1,605 | 1,923 | 0 |
| 31 Mar 21 | 6,832 | 1,536 | 1,719 | 0 |
| 31 Dec 20 | 6,946 | 1,587 | 1,618 | 0 |
| 30 Sep 20 | 6,683 | 1,552 | 1,442 | 0 |
| 30 Jun 20 | 6,268 | 1,458 | 1,351 | 0 |
| 31 Mar 20 | 6,399 | 1,456 | 1,422 | 0 |
| 31 Dec 19 | 6,253 | 1,446 | 1,442 | 0 |
| 30 Sep 19 | 5,926 | 1,318 | 1,395 | 0 |
| 30 Jun 19 | 5,675 | 1,273 | 1,371 | 0 |
| 31 Mar 19 | 5,439 | 1,240 | 1,336 | 0 |
| 31 Dec 18 | 5,382 | 1,207 | 1,273 | 0 |
| 30 Sep 18 | 5,205 | 1,250 | 1,310 | 0 |
| 30 Jun 18 | 5,248 | 1,307 | 1,278 | 0 |
| 31 Mar 18 | 5,115 | 1,294 | 1,202 | 0 |
| 31 Dec 17 | 4,725 | 1,234 | 1,168 | 0 |
| 31 Dec 16 | 4,206 | 1,087 | 860 | 0 |
| 31 Dec 15 | 3,748 | 643 | 824 | 0 |
| 31 Dec 14 | 1,453 | -253 | 939 | 0 |
Quality Earnings: AGP has a high level of non-cash earnings.
Growing Profit Margin: AGP's current net profit margins (8.4%) are lower than last year (10.9%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: AGP's earnings have grown by 4.1% per year over the past 5 years.
Accelerating Growth: AGP's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: AGP had negative earnings growth (-0.3%) over the past year, making it difficult to compare to the Pharmaceuticals industry average (-3.3%).
Return on Equity
High ROE: AGP's Return on Equity (14.7%) is considered low.